We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tanner Pharma is not a very substantial enterprise as far as I can see. Why would the Ministry order through them?
Unless of course Immu choose to supply only through them to get a bigger slice. Any industry insider know?
enders > 2020 > Award notice
Coronavirus AG Rapid Test Cassette (Swab)
A Contract Award Notice
by DEPARTMENT OF HEALTH & SOCIAL CARE
Source
Contracts Finder
Type
Contract (Products)
Duration
2.5 month
Value
£148M
Sector
HEALTH
Published
26 Nov 2020
Delivery
09 Oct 2020 to 31 Dec 2020
Deadline
09 Oct 2020 00:00
Concepts
coronavirus ag rapid test cassette
diagnostic supplies
swab
lateral flow kits
Location
1 buyer
Department of Health & Social Care
London
1 supplier
Tanner Pharma
St Albans
Description
Contract for Lateral Flow kits and consumables
Award Detail
1 Tanner Pharma (None)
Value: £148,500,000
CPV Codes
33124130 - Diagnostic supplies
Other Information
20201007_DHSC_Order Form_Tanner Pharma_2_Redacted
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEEG/Tye6EkUGS8V...
Justification_for_Use_of_Article_32__Tanner Pharma
https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kEEF/cT2XurfvnUw...
Reference
CF-0047100D0O000000rwimUAA1
Domains
atamis.co.uk
dhsc.gov.uk
atamis-1928.cloudforce.com
Sell price ticking up slowly
Exciting times ahead,slow rise is good
Don't forget Covid-19 tests are only one part of the company, my hope is that this will open doors worldwide for their testing machines.
Imo, with this lateral flow antigen test, it would generate minimum of £100 million revenue for the company.
Omega diagnostics is a partner with IDS - they make 69 allergy tests for them
Hi why is the spread so massive on this share?
The nice thing, is that at this level, it is not overpriced irrespective how well they do selling the sars cov2 antigen test.
The price had dropped because of the slowdown in routine testing because of covid, volumes for this has started to return (although may have been impacted by the most recent covid wave). This make it far less of a risk than some of the other other 'covid stocks' .
...the beginning. this will shine a bright torchlight on the work of this microcap and should lead to much new business and quite possibly takeover interest.
This is the only UK company that offers Lateral flow antigen test .
Those are the covid-19 tests for their machines of which they can do up to 10,000 per machine per day. This rns is for their brand new 15 minute tests which we should now get impressive sales figures on a regular basis raising the sp each time. 12 months from now the sp will many multiples of today's price which is why I said it's a great long term hold.
Daft, unfortunately the interim results suggest they don't which doesn't bode well, though they could have bid for the LFT tender which would change things somewhat.
IDS has launched a number of products for COVID-19 testing in H1, but revenues from these products have so far not been able to make up for the impact of the decline in the market for routine testing
Is the test provided by Siemens Healthcare? Performance spec matches.
https://static.healthcare.siemens.com/siemens_hwem-hwem_ssxa_websites-context-root/wcm/idc/groups/public/@global/@lab/@poc/documents/download/mdew/mdez/~edisp/antigen_rapid_covid-19_antigen_test_final_10_19_20-07531568.pdf
They have bigger chance to win government’s contracts worth £100 billion Operation Moonshoot. Other countries are also preferring to use lft ag test for mass testing.
I bought more. Very undervalued if u compare market cap of ODX and Avacta.
Not sure I understand what you on about trades going through as normal
The stock is halted on Trading212 since 8:15 AM cause I have Buy Order pending since then... and also chart is not moving :(
Both tests can be performed by a trained healthcare professional in community locations (e.g. workplaces, schools, doctors' surgeries) without the need for any laboratory equipment. These tests determine the presence of the SARS-CoV-2 nucleocapsid protein antigen using direct nasopharyngeal swab samples, providing a result within 15 minutes.
Same story as Avacta - initially trying saliva but then pivoting to swab (as an intrim measure??)
From interim results- We are working on the development of a saliva-based rapid test for SARS-CoV-2 antigens. This manual test, which has the potential for self-administered use, would allow for immediate identification of individuals with an elevated amount of SARS-CoV-2 virus and be extremely helpful for curtailing the spread of the virus. In addition, it will overcome the shortcoming of presently used rapid tests based on nasopharyngeal swabs, which rely on sampling by professional staff only.
Note IDH are targeting the nucleocore proteins with these LFT's -these are >10x more abundant/per viron than the S1 spike protein.
Like Today s rns others will dyor ,also watching syme as buyers move back in there again
LIKE READING THIS RNS AY IDS
Launch of SARS-CoV-2 Antigen Rapid Tests
Immunodiagnostic Systems Holdings plc (IDS), a specialty solution provider to the clinical laboratory diagnostic market, announces that two SARS-CoV-2 Antigen Rapid Test kits are now available for sale in the UK, European Union and other countries which accept the CE mark as the basis of regulatory approval.
Both tests can be performed by a trained healthcare professional in community locations (e.g. workplaces, schools, doctors' surgeries) without the need for any laboratory equipment. These tests determine the presence of the SARS-CoV-2 nucleocapsid protein antigen using direct nasopharyngeal swab samples, providing a result within 15 minutes.
Both fast and easy to use tests are based on the lateral flow principle: one in a cassette format, one in a test card format. These tests are provided by partners of IDS, and have been assessed by the manufacturers as having the following performance characteristics:
Specificity
Sensitivity
Time to Result
Lateral Flow cassette
99.2%
96.7%
15 minutes
Lateral Flow card
99.3%
92.0%
15 minutes
IDS now offers a comprehensive portfolio of SARS-CoV-2 antigen and antibody tests for the laboratory as well as for community locations; additional information of our SARS-CoV-2 assay portfolio can be found on the IDS website at www.idsplc.com.
Thank luck, I thought I was dreaming this morning when I read the rns at 7am, and no response here until 7.30. GLA
Nice rise, remember this has hit 1200p in the past.
IDS now offers a comprehensive portfolio of SARS-CoV-2 antigen and antibody tests for the laboratory as well as for community locations; additional information of our SARS-CoV-2 assay portfolio can be found on the IDS website at www.idsplc.com.
15 MINURES
Lateral Flow cassette
99.2%
96.7%
15 minutes